Abstract
The presence of primary neuroendocrine tumors in the liver is still a matter of controversy. We present a case of a somatostatin-receptor-positive mass of the liver in the 68Ga-DOTATOC PET/CT. No other primary tumor was found after conventional imaging, endoscopically, and after liver-segment resection. Immunohistochemically, a constellation of findings was found to be compatible with a primary neuroendocrine neoplasm of the liver.
| Original language | English |
|---|---|
| Journal | Clinical Nuclear Medicine |
| Volume | 46 |
| Issue number | 5 |
| Pages (from-to) | 409-410 |
| Number of pages | 2 |
| ISSN | 0363-9762 |
| DOIs | |
| Publication status | Published - 01.05.2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
DFG Research Classification Scheme
- 2.22-17 Endocrinology, Diabetology, Metabolism
- 2.22-14 Hematology, Oncology
- 2.23-06 Molecular and Cellular Neurology and Neuropathology
Fingerprint
Dive into the research topics of 'Primary Neuroendocrine Neoplasia of the Liver'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver